Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Atrial fibrillation progression"'
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 30-37 (2020)
Aim: to study the association of rs2200733 polymorphism with antiarrhythmic efficacy of amiodarone, propafenone and allapinin in the prevention of atrial fibrillation (AF) progression.Material and methods. In order to comparatively evaluate the effec
Externí odkaz:
https://doaj.org/article/708b329f76b44912b7f347eb1e3a01a4
Autor:
Venkatesh Ravi, Dominik Beer, Grzegorz M. Pietrasik, Jillian L. Hanifin, Sara Ooms, Muhammad Talha Ayub, Timothy Larsen, Henry D. Huang, Kousik Krishnan, Richard G. Trohman, Pugazhendhi Vijayaraman, Parikshit S. Sharma
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 22 (2020)
Background Conventional right ventricular pacing (RVP) has been associated with an increased incidence of atrial fibrillation (AF). We sought to compare the occurrence of new‐onset AF and assessed AF disease progression during long‐term follow‐
Externí odkaz:
https://doaj.org/article/3f912f41bc6544b1a1b87edb371bd0c6
Autor:
Petra Büttner, Jürgen G. Okun, Jana Hauke, Erik Holzwirth, Danilo Obradovic, Gerhard Hindricks, Holger Thiele, Jelena Kornej
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 29, Iss , Pp 100554- (2020)
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases. A potential involvement of increas
Externí odkaz:
https://doaj.org/article/c0b315c7422147e49ead8d08773b0c7a
Autor:
van de Lande, M.E., Rama, R.S., Koldenhof, T., Arita, V.A., Nguyen, B.O., van Deutekom, C., Weberndorfer, V., Crijns, H.J.G.M., Hemels, M.E.W., Tieleman, R.G., de Melis, M., Schotten, U., Linz, D., Van Gelder, I.C., Rienstra, M.
Publikováno v:
EP Europace. Oxford University Press
AimsAtrial fibrillation (AF) progression is associated with adverse outcome, but the role of the circadian or diurnal pattern of AF onset remains unclear. We aim to assess the association between the time of onset of AF episodes with the clinical phe
Publikováno v:
Journal of the American College of Cardiology. 79(19):1932-1948
The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Although the management of AF historically focused on decreasing AF recurrence, it evolved over time in
Autor:
Petra Büttner, Laura Ueberham, M. B. Shoemaker, Dan M. Roden, Borislav Dinov, Gerhard Hindricks, Andreas Bollmann, Daniela Husser
Publikováno v:
Frontiers in Genetics, Vol 9 (2018)
Atrial fibrillation (AF) is a multifactorial disease with a strong genetic background. It is assumed that common and rare genetic variants contribute to the progression and recurrence of AF. The pathophysiological impact of those variants, especially
Externí odkaz:
https://doaj.org/article/b13ad7a87e274499a57e79c43ba780b5
Autor:
David Filgueiras-Rama, Nicasio Pérez-Castellano, Xavier Viñolas, Juan José González-Ferrer, Aníbal Rodríguez, Ignasi Anguera, José Martínez-Ferrer, Javier Jiménez-Díaz, Javier Alzueta, José María Lillo-Castellano, José Manuel Alfonso-Almazán, Luis Borrego, Javier Cremades García, Arcadio García-Alberola, Julián Pérez-Villacastín, Jorge G. Quintanilla, Victoria Cañadas-Godoy, Juan Carlos Rodríguez-Pérez, José Jalife, Juan Gabriel Martinez, Manuel Marina-Breysse, Luisa Pérez-Álvarez
Publikováno v:
Europace
Repisalud
Instituto de Salud Carlos III (ISCIII)
EUROPACE
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Dipòsit Digital de la UB
Universidad de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repisalud
Instituto de Salud Carlos III (ISCIII)
EUROPACE
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Dipòsit Digital de la UB
Universidad de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Atrial electrical remodelling (AER) is a transitional period associated with the progression and long-term maintenance of atrial fibrillation (AF). We aimed to study the progression of AER in individual patients with implantable devices and AF episod
Autor:
Sander M. J. van Kuijk, Isabelle C. Van Gelder, Richard J Folkeringa, Harry J.G.M. Crijns, Jan G.P. Tijssen, Arif Elvan, Raymond Tukkie, Robert G. Tieleman, Jan Elders, Nikki A H A Pluymaekers, Tim Koldenhof, Patrick Bronzwaer, Justin G.L.M. Luermans, Michiel Rienstra, Petra Wijtvliet
Publikováno v:
EP Europace, 24(3), 384-389. Oxford University Press
Europace, 24(3). Oxford University Press
Europace, 24(3), 384-389. Oxford University Press
Europace, 24(3). Oxford University Press
Europace, 24(3), 384-389. Oxford University Press
AimsWe hypothesize that in patients with paroxysmal atrial fibrillation (AF), verapamil is associated with lower AF progression compared to beta blockers or no rate control.Methods and resultsIn this pre-specified post hoc analysis of the RACE 4 rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57db64907356f3d0ee668c4c10d9d0b8
https://cris.maastrichtuniversity.nl/en/publications/24de402d-3841-476d-8a10-b6f7d70deed3
https://cris.maastrichtuniversity.nl/en/publications/24de402d-3841-476d-8a10-b6f7d70deed3
Publikováno v:
Europace. 22(8):1162-1172
Aims Atrial fibrillation (AF) often starts as a paroxysmal self-terminating arrhythmia. Limited information is available on AF patterns and episode duration of paroxysmal AF. In paroxysmal AF patients, we longitudinally studied the temporal AF patter
Autor:
Isabelle C Van Gelder, Michiel Rienstra, Harry J G M Crijns, Henri M Spronk, Elton A M P Dudink, Ernaldo G Marcos, Ruben R De With
Publikováno v:
EP Europace, 22(3), 352-360. Oxford University Press
Europace, 22(3), 352-360. Oxford University Press
Europace, 22(3), 352-360. Oxford University Press
Aims Atrial fibrillation (AF) is a progressive disease, but identifying patients at risk for AF progression is challenging. We aimed to identify factors associated with AF progression. Methods and results Atrial fibrillation progression was assessed